The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...

Last month, the Center for Global Development (CGD), the White House Office of Science and Technology Policy, and the Office of Management and Budget co-hosted an Evidence Forum as part of the White House Year of Evidence for Action, featuring USAID Administer Samantha Power. The event celebrated pr...

Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.

PEPFAR’s new strategy—to be released in final form later this year—focuses on how to accelerate progress toward epidemic control amidst continued impacts from COVID-19, while also strengthening core health system functions as well as partnership and coordination efforts; this is precisely what the c...

Decision makers within governments, aid agencies, multilateral organizations, and NGOs have not yet fully harnessed the value of evidence for better public policies. To address this missed opportunity, we convened a virtual working group from 2020 to 2022, bringing together 40 policymakers and exper...

As the GFF wraps up its sixth year of operations, enters its next strategic period, and undertakes an important replenishment campaign to raise an additional $2.5 billion in trust fund resources, we are excited to share new work on the role of the GFF in improving the impact of health spending for R...